Browsing publications by Dr David Kavanagh

Newcastle AuthorsTitleYearFull text
Rachel Challis
Dr Edwin Wong
Dr Holly Anderson
Dr Valerie Wilson
Dr Vicky Brocklebank
et al.
A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H–Related 3 Gene in Atypical Hemolytic Uremic Syndrome2016
Professor Neil Sheerin
Dr David Kavanagh
Professor Tim Goodship
Dr Sally Johnson
A national specialised service in England for atypical haemolytic uraemic syndrome – the first year’s experience2016
Dr Patrick Gleeson
Dr Valerie Wilson
Tom Cox
Dr Kate Smith-Jackson
Dr David Kavanagh
et al.
Chromosomal rearrangement – a rare cause of complement factor I associated atypical haemolytic uraemic syndrome2016
Dr David Kavanagh
Dr Kate Smith-Jackson
Eculizumab in children with hemolytic uremic syndrome2016
Dr Vicky Brocklebank
Dr Edwin Wong
Dr Kevin Marchbank
Professor Tim Goodship
Dr David Kavanagh
et al.
The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies2016
Rachel Challis
Dr Edwin Wong
Dr Valerie Wilson
Dr Kevin Marchbank
Dr Mauro Santibanez Koref
et al.
Thrombotic microangiopathy in INF2 mediated renal disease2016
Dr David Kavanagh
Rachel Challis
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature2016
Dr Edwin Wong
Dr David Kavanagh
Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome2015
Dr Veronique Fremaux-Bacchi
Professor Tim Goodship
Dr David Kavanagh
Atypical aHUS: State of the art2015
Rachael Watson
Dr Karim Bennaceur
Catriona Barker
Dr David Kavanagh
Professor Tim Goodship
et al.
Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)2015
123456789